Hydrofarm Q2 Revenue Declines 27% YoY, What About Net Loss?

Hydrofarm Holdings Group, Inc. HYFM released financial results for its second quarter ended June 30, 2022, revealing net sales decreased 27% to $97.5 million compared to $133.8 million in Q2 2021.

Q2 2022 Financial Highlights vs. Prior Year Period:

  • Gross profit decreased 75% to $7.3 million compared to $29.6 million.

  • Net loss was $(203.3) million, or $(4.53) per diluted share, compared to net income of $2.3 million, or $0.05 per diluted share. Net loss in the second quarter of 2022 included a non-cash charge of $189.6 million in goodwill impairment and a $10.2 million inventory reserve.

  • Adjusted EBITDA decreased to $(6.8) million compared to $16.2 million.

Bill Toler, chairman and CEO of Hydrofarm, stated, “Our second quarter results reflect the ongoing impact of the hydroponic industry recession in the U.S. and Canada. Nonetheless, we took positive steps to lower our cost structure and maintain a solid liquidity position."

Balance Sheet and Liquidity

As of June 30, 2022, the company had $27.4 million in cash, cash equivalents and restricted cash, an aggregate principal amount of debt outstanding of $126.7 million, $15.3 million in contingent payments and approximately $70 million of available borrowing capacity under its revolving credit agreement. The company decreased its net debt by approximately $14.1 million during the second quarter by improving its working capital position and controlling costs.

Full Year 2022 Outlook:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsBill Toler
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...